XZXuyu Zhou

Xuyu Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xuyu Zhou has a total of 180 co-authors. Here are the top co-authors by number of shared publications:

  • Jie Guo

    Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China

    14 shared publications
  • Jianhua Zhang

    CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China

    10 shared publications
  • Wei Zhang

    CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Science (CAS), Beijing 100101, China

    9 shared publications
  • Liping Li

    Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China

    8 shared publications
  • Wei Xu

    Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China

    8 shared publications
  • Baidong Hou

    Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences (CAS), Beijing 100101, China

    7 shared publications

Latest Publications

  • ANKRD11 deficiency reprograms CD8+ T cell differentiation to enhance immunity in chronic infection and cancer

    by Wei Xu, Jie Guo, Xue Cao, Liping Li, Pei Xiao, Xinchao Zhang, Qiuzhu Jin, Fuping Zhang, Baidong Hou, Minghui Li, et al.

    CD8+ T cell dysfunction is a major obstacle to hepatitis B virus (HBV) clearance and antitumor immunity. Here, using a humanized mouse model, we identify a T cell receptor targeting a clinically relevant HBV epitope and reveal ANKRD11 as a key epigenetic regulator of CD8+ T cell dysfunction in chronic infection and tumors. Ankrd11 knockout in CD8+ T cells enhances HBV-specific T cell proliferation and effector differentiation, especially under immunosuppressive conditions, via AP-1 family gene upregulation. Loss of Ankrd11 both drives the conversion of progenitor exhausted T cells into terminally exhausted T cells, and reprograms PD-1−TOX− tolerant cells into functional effectors, improving antiviral and antitumor responses. Ankrd11-deficient T cells show increased granzyme and superior effector function, enhancing viral control and tumor regression. These findings position ANKRD11 as a promising immunotherapy target for chronic HBV infection and cancer.

  • Open Access

    H3.3 chaperone Hira primes the effector program and function of regulatory T cells

    by Xiangxiang Cao, Mengjie Lv, Zhihan Lv, Shuting Zheng, Xinyi Tan, Jiyu Ding, Wei Liang, Guohong Li, Xuyu Zhou, Mingzhao Zhu

    Foxp3 + regulatory T (Treg) cells need to differentiate into effector Treg (eTreg) cells to maintain immune tolerance and tissue homeostasis. While several transcription factors such as Batf and JunB have been reported to be essential for eTreg differentiation and function, the underlying epigenetic mechanism remains unclear. Here, we show that the histone variant H3.3 is enriched in tissue Tregs compared to splenic Tregs and its chaperone Hira is a critical regulator of Treg effector program. Treg specific-deletion of Hira resulted in reduced eTreg population, impaired suppressive function and multi-organ inflammation in mice. Mechanistically, Hira-dependent H3.3 deposition establishes a permissive epigenetic environment by enhancing chromatin accessibility, facilitating H3K36me3 and preventing H3K27me3 modifications on loci of genes enriched for AP-1 family binding motifs and associated with Treg effector function. Furthermore, overexpression of Batf in Hira -deficient Treg cells largely ameliorates their regulatory defects. Together, our findings reveal a previously unreported epigenetic mechanism critical for Treg effector differentiation and function.

  • Open Access

    Ex-Tregs: From controversial artifact to therapeutic target

    by Liping Li, Minghui Li, Xuyu Zhou

  • Open Access

    TCR signal strength determines T reg instability and discrimination of self versus non-self antigens

    by Liping Li, Jie Guo, Ruiqiao He, Xin Chai, Chang Guo, Wei Xu, Xue Cao, Qiuzhu Jin, Fuping Zhang, Baidong Hou, et al.

    Regulatory T cells (Tregs) expressing autoreactive T-cell receptors (TCRs) maintain immune self-tolerance, yet their fate upon antigen encounter remains unclear. Although selected in the thymus for high-affinity self-recognition, the cross-reactive nature of the TCR repertoire allows some Tregs to also recognize foreign antigens with high affinity. Here, we identify cross-reactive destabilization, a process in which high-affinity recognition of foreign antigens erodes Treg stability and redirects lineage fate. Using a thymic-derived Treg (tTreg) TCR capable of recognizing both self and foreign antigens distinct from the self-ligand that mediated its thymic selection, we show that stimulation with high-affinity non-self agonists induces Foxp3 loss and conversion into effector-like ex-Tregs, whereas self-antigen stimulation preserves lineage stability. Treg instability also increases with age and correlates with activation, suggesting that cumulative foreign-antigen exposure drives this process. These findings reveal a signal-strength–dependent model in which strong TCR engagement induces cross-reactive destabilization to balance immune responsiveness and self-tolerance. One Sentence Summary: Foreign antigen-driven destabilization of T reg cells balances immunity and tolerance

  • Open Access

    Ankrd11 deficiency reverses the dysfunction of chronic HBV-specific T-cell

    by Xuyu Zhou, Wei Xu, Jie Guo, Xue Cao, Liping Li, Qiuzhu Jin, Fuping Zhang, Baidong Hou, Minghui Li

    CD8+ T cell dysfunction, driven by intricate molecular mechanisms, poses a major obstacle to hepatitis B virus (HBV) clearance in chronic infection. Using a highly humanized mouse model, we identified a T cell receptor (TCR) targeting a dominant epitope essential for HBV clearance in clinical settings. We further uncovered Ankrd11, an epigenetic regulator critical for sustaining CD8+ T cell dysfunction during chronic infection. Strikingly, Ankrd11 knockout in CD8+ T cells markedly enhanced HBV-specific T cell proliferation, particularly in immunosuppressive environments, through upregulated AP-1 family gene expression. Additionally, Ankrd11-deficient T cells exhibited robust granzymes production and superior effector functions, resulting in potent antiviral and anti-tumor activity. These findings open new avenues for immunology and virology research, offering promising therapeutic strategies against chronic HBV infection.

  • Open Access

    Comparison of antigen-specific B cell responses reveals disparity in immunogenicity and memory B cell formation across COVID-19 vaccine platforms

    by Chang Guo, Xin Chai, Maidaiti Baerlike, Yingping Liu, Yao Wang, Fei Shao, Qingrui Huang, Weiguo Zhang, Shan Cen, Yijie Dong, et al.


  • Open Access

    The histone lysine methyltransferase MLL1 regulates the activation and functional specialization of regulatory T cells

    by Ting Wang, Jie Guo, Liping Li, Qiuzhu Jin, Fuping Zhang, Baidong Hou, Yan Zhang, Xuyu Zhou


  • Open Access

    Identification and affinity enhancement of T-cell receptor targeting a KRASG12V cancer neoantigen

    by Mengyu Zhang, Wei Xu, Lingjie Luo, Fenghui Guan, Xiangyao Wang, Pei Zhu, Jianhua Zhang, Xuyu Zhou, Feng Wang, Sheng Ye

    Neoantigens derived from somatic mutations in Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS), the most frequently mutated oncogene, represent promising targets for cancer immunotherapy. Recent research highlights the potential role of human leukocyte antigen (HLA) allele A*11:01 in presenting these altered KRAS variants to the immune system. In this study, we successfully generate and identify murine T-cell receptors (TCRs) that specifically recognize KRAS8–16G12V from three predicted high affinity peptides. By determining the structure of the tumor-specific 4TCR2 bound to KRASG12V-HLA-A*11:01, we conduct structure-based design to create and evaluate TCR variants with markedly enhanced affinity, up to 15.8-fold. This high-affinity TCR mutant, which involved only two amino acid substitutions, display minimal conformational alterations while maintaining a high degree of specificity for the KRASG12V peptide. Our research unveils the molecular mechanisms governing TCR recognition towards KRASG12V neoantigen and yields a range of affinity-enhanced TCR mutants with significant potential for immunotherapy strategies targeting tumors harboring the KRASG12V mutation.


  • Open Access

    Antiviral memory B cells exhibit enhanced innate immune response facilitated by epigenetic memory

    by Xiping Zhu, Sheng Hong, Jiachen Bu, Yingping Liu, Can Liu, Runhan Li, Tiantian Zhang, Zhuqiang Zhang, Liping Li, Xuyu Zhou, et al.

    The long-lasting humoral immunity induced by viral infections or vaccinations depends on memory B cells with greatly increased affinity to viral antigens, which are evolved from germinal center (GC) responses. However, it is unclear whether antiviral memory B cells represent a distinct subset among the highly heterogeneous memory B cell population. Here, we examined memory B cells induced by a virus-mimicking antigen at both transcriptome and epigenetic levels and found unexpectedly that antiviral memory B cells exhibit an enhanced innate immune response, which appeared to be facilitated by the epigenetic memory that is established through the memory B cell development. In addition, T-bet is associated with the altered chromatin architecture and is required for the formation of the antiviral memory B cells. Thus, antiviral memory B cells are distinct from other GC-derived memory B cells in both physiological functions and epigenetic landmarks.


  • Open Access

    Adaptive plasticity of natural interleukin-35-induced regulatory T cells (Tr35) that are required for T-cell immune regulation

    by Xundong Wei, Jianhua Zhang, Jian Cui, Wei Xu, Gang Zhao, Chang Guo, Wei Yuan, Xuyu Zhou, Jie Ma

    Background: IL-35 potently inhibits immune responses both in vivo and in vitro. However, the specific characteristics of IL-35-producing cells, including their developmental origin, cellular phenotype, and function, are unknown.